HOME >> MEDICINE >> NEWS
Small, open-label study shows potential use of novel antibiotic rifaximin for Crohn's disease

is an abnormal response to bacteria in the gastrointestinal tract. It is this supposition that led researchers to analyze treatment with rifaximin, a nonabsorbed oral antibiotic that is gut-selective with broad-spectrum in vivo activity against gram-positive and gram-negative enteric organisms.

Results of the analysis suggest that rifaximin may be a safe and effective treatment for Crohn's Disease. Researchers say that this small assessment shows promise for those afflicted with Crohn's Disease, and that the role of rifaximin in the induction and maintenance of remission of inflammatory bowel disease, as well as the optimal dosing schedule, should be explored in well-controlled, double-blinded clinical studies.

Crohn's Disease is a chronic inflammatory disease of the intestines and is frequently referred to as inflammatory bowel disease (IBD). It primarily causes ulcerations (breaks in the lining) of the small and large intestines. IBD affects approximately 500,000 to 2 million people in the United States. Men and women are equally affected. Common symptoms of Crohn's Disease include abdominal pain, diarrhea, and weight loss. Less common symptoms include poor appetite, fever, night sweats, rectal pain, and rectal bleeding. The symptoms of Crohn's Disease are dependent on the location, the extent, and the severity of the inflammation. There is currently no known cure for Crohn's Disease.


'"/>


18-May-2005


Page: 1 2

Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. New study counts the economic cost of persistent pain in Australia
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Most seniors now have drug coverage, U-M study shows
7. To gain muscle and lose fat, drink milk: study
8. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
9. Even older women at high risk have little interest in being tested for HIV, study finds
10. Metabolic study in mice could lead to good cholesterol boosters
11. Michigan-CDC study supports value of social restrictions during influenza pandemics

Post Your Comments:
(Date:6/20/2013)... During a June 13 panel discussion on ... Health Benefit Exchange confirmed the existence of the Federal ... industry consider,” writes panel moderator Steve Davis in a ... unicorns and leprechauns.” , “We are the only state ... Hub live,” Rebecca Pearce told attendees at Gorman Health ...
(Date:6/20/2013)... Mobile, a leading manufacturer and distributor of wholesale-direct-to-consumer ... of 16GB version of the Mini Studio Android tablet. ... tablet that is a direct competitor to the iPad ... it will be launched at promotional price at $121 ... Mini STUDIO is part of the Handgiftbox.com “STUDIO Series,” ...
(Date:6/20/2013)... Emotional abuse expert and author, Lisa Kroulik, has ... used by emotional abusers. In the book, she ... spoken to for days, being blamed for everything, and ... and more in her marriage to an emotionally abusive ... years because she did not realize her ex-husband's behavior ...
(Date:6/20/2013)... Bournemouth, Dorset (PRWEB) June 20, 2013 ... disease) and more serious medical conditions because they do ... of Eludril mouthwash and Elgydium toothpaste. , Seven million ... leaving it 48 hours between brushes, latest data from ... per cent of people polled by the BDHF also ...
(Date:6/20/2013)... CT (PRWEB) June 20, 2013 Startups ... to energize their sales or test new markets, and ... U.S. now have a new sales outsourcing ... sustained sales revenue. , Strategy Sales Partners ... professionals. Founded by business owners for business owners, Strategy ...
Breaking Medicine News(10 mins):Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2Health News:Android Tablet PC Mini Studio with Android 4.1 with 16GB is Here at $121 Only at Handgiftbox.com 2Health News:Lisa Kroulik Empowers Women to Recognize Emotional Abuse in Intimate Relationships 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3
(Date:6/19/2013)...  Decision Resources, one of the world,s leading ... issues, finds that, for the treatment of rheumatoid ... rheumatologists cite a therapy,s induction of remission as ... prescribing decisions. Over 60 percent and 70 percent ... percentage of patients achieving remission at six months ...
(Date:6/19/2013)... N.Y. , June 19, 2013 ... sourcing company servicing all branches of government from ... they have expanded their facilities to include complex ... designed and fabricated some very complex aluminum parts ... continue to expand our capabilities to service government ...
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- Today leading web researchers Change Sciences ... Pharmaceutical web sites for usability, engagement, and conversion. The ... platform, which compares how people experience sites with competitors ... The top three performers are easier to use, ... bottom performers have usability problems, lack aspects of design ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2Amerivet Solutions Expands to Manufacture Complex Metal Designs 2Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2
Cached News: